Company Filing History:
Years Active: 2008-2013
Title: The Innovations of Per Svenningsson
Introduction
Per Svenningsson is a notable inventor based in New York, NY (US), recognized for his contributions to the field of neuroscience and psychopharmacology. He holds two patents that focus on innovative methods for diagnosing and treating disorders related to serotonin and dopamine signaling pathways. His work has significant implications for the development of novel psychotherapeutic agents.
Latest Patents
Svenningsson's latest patents include "Diagnosis of Depression," which relates to the use of p11 as a drug target and a tool for diagnosing, treating, and developing therapies for p11/5-HT receptor-related disorders. This invention also involves p11 knock-out and transgenic animals as models for developing new psychotherapeutic agents. Another patent, "Compositions and Methods for Modulation of DARPP-32 Phosphorylation," provides methods and compositions for modulating the phosphorylation of DARPP-32 in serotonergic receptor intracellular signaling pathways. This invention aims to treat serotonergic and dopamine-related disorders by identifying agents that modulate the activities of various signaling molecules.
Career Highlights
Throughout his career, Per Svenningsson has worked with prestigious institutions, including The Rockefeller University and Intra-Cellular Therapies, Inc. His research has contributed to a deeper understanding of the molecular mechanisms underlying mood disorders and has paved the way for potential new treatments.
Collaborations
Svenningsson has collaborated with esteemed colleagues such as Paul Greengard and Sergey V Rakhilin, further enhancing the impact of his research in the scientific community.
Conclusion
Per Svenningsson's innovative work in the field of neuroscience has led to significant advancements in the diagnosis and treatment of mood disorders. His patents reflect a commitment to improving mental health through scientific research and innovation.